Nektar Therapeutics NKTR:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 05/03/24 EDT
1.55quote price arrow down-0.02 (-1.27%)
Volume
2,280
Close
1.57quote price arrow down-0.10 (-5.99%)
Volume
1,128,845
52 week range
0.41 - 1.79
Loading...
  • Open1.74
  • Day High1.74
  • Day Low1.55
  • Prev Close1.67
  • 52 Week High1.79
  • 52 Week High Date05/02/24
  • 52 Week Low0.41
  • 52 Week Low Date11/13/23

Key Stats

  • Market Cap288.28M
  • Shares Out183.62M
  • 10 Day Average Volume1.70M
  • Dividend-
  • Dividend Yield-
  • Beta0.73
  • YTD % Change177.88

KEY STATS

  • Open1.74
  • Day High1.74
  • Day Low1.55
  • Prev Close1.67
  • 52 Week High1.79
  • 52 Week High Date05/02/24
  • 52 Week Low0.41
  • 52 Week Low Date11/13/23
  • Market Cap288.28M
  • Shares Out183.62M
  • 10 Day Average Volume1.70M
  • Dividend-
  • Dividend Yield-
  • Beta0.73
  • YTD % Change177.88

RATIOS/PROFITABILITY

  • EPS (TTM)-1.46
  • P/E (TTM)-1.08
  • Fwd P/E (NTM)-2.05
  • EBITDA (TTM)-126.11M
  • ROE (TTM)-110.95%
  • Revenue (TTM)90.122M
  • Gross Margin (TTM)62.53%
  • Net Margin (TTM)-306.31%
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date05/09/2024
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Nektar Therapeutics

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Nektar Therapeutics is a clinical-stage, research-based drug discovery biopharmaceutical company. The Company is focused on discovering and developing medicines in the field of immunotherapy. The Company has a research and development pipeline of investigational medicines in immunology and oncology. In oncology, it is focused on developing medicines based on targeting biological pathways that stimulate and sustain the body’s immune response to fight cancer. Its pipeline...
Robert Chess
Independent Chairman of the Board
Howard Robin
President, Chief Executive Officer, Director
Sandra Gardiner
Interim Chief Financial Officer
Address
455 Mission Bay Boulevard South
San Francisco, CA
94158
United States

Top Peers

SYMBOLLASTCHG%CHG
GTHX
G1 Therapeutics Inc
4.49+0.05+1.13%
TSVT
2Seventy Bio Inc
4.76-0.17-3.45%
ENTA
Enanta Pharmaceuticals Inc
15.17+1.26+9.06%
PSTX
Poseida Therapeutics Inc
2.87+0.08+2.87%
ADCT
ADC Therapeutics SA
4.90+0.17+3.59%